v3.26.1
ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)
3 Months Ended
Mar. 31, 2026
Accounting Policies [Abstract]  
SCHEDULE OF DISAGGREGATION OF REVENUE

The following is a summary of the disaggregation of revenue for the three months ended March 31, 2026 and 2025:

 

   2026   2025 
   Three Months Ended 
   March 31, 
   2026   2025 
Product revenue - distribution services  $225,665   $10,668,287 
Pharmacy retail sales   1,134,416    114,676 
Third party logistics services   199,482    80,480 
Net revenues  $1,559,563   $10,863,443 
SCHEDULE OF POTENTIALLY DILUTIVE ITEMS OUTSTANDING

The following potentially dilutive securities were excluded from the computation of diluted net loss per share for the three months ended March 31, 2026 and 2025:

 

   2026   2025 
   March 31, 
   2026   2025 
         
Unvested restricted common stock    1,182,121    10,248,491 

Unissued director share awards

   60,000    - 
Warrants   15,457,644    - 
Convertible notes   20,027,114    - 
Total potentially dilutive shares   36,726,879    10,248,491